AML1 Antibody

About the Target

AML1 (also known as Runx1, CBFA2, and PEBP2αB) is a member of the core binding factor (CBF) family of transcription factors. It forms a heterodimeric complex that binds to specific DNA sequences to regulate hematopoietic gene expression. It contains a highly evolutionally conserved Runt domain that facilitates DNA binding and heterodimerization with its partner protein, CBFβ. Depending on the literature source, RUNX1 may also be discussed as AML1.

Reported cellular context includes nucleus, which can matter when signal is compared across treatments or changing cell states. Following RUNX1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

RUNX1 is commonly interpreted in the context of cancer, developmental biology, and epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• signal enrichment within nucleus relative to the broader cellular background
• changes associated with proliferative state, oncogenic signaling, or treatment response
• stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
• links between target behavior and transcriptional or chromatin-state changes

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for RUNX1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in RUNX1 reflect biology rather than handling. When interpreting RUNX1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep RUNX1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.